Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Driver
4.2 Challenges


5. Global Vaccines Market

5.1 Adult Vaccines Market
5.2 Pediatric (Infant) Vaccines Market


6. Global Vaccinated People

6.1 Adult Vaccinated People
6.2 Pediatric (Infant) Vaccinated People


7. Global Vaccines Market & people Share Analysis

7.1 Vaccine Market Share
7.2 Vaccinated People Share


8. By Categories – Global Vaccines Market & People Share

8.1 Adult Vs Pediatric (Infant) Vaccines Market Share
8.2 Adult Vs Pediatric (Infant) Vaccines Number Share


9. Disease wise – Vaccines Market and Forecast

9.1 Influenza – Total Vaccines Market

9.1.1 Influenza – Adult Vaccines Market
9.1.2 Influenza – Pediatric (Infant) Vaccines Market

9.2 Cervical Cancer (HPV) – Vaccines Market

9.3 Zoster (Shingles) – Vaccines Market

9.4 MMR (Measles, Mumps, and Rubella Vaccine) – Total Vaccines Market

9.4.1 MMR – Adult Vaccines Market
9.4.2 MMR – Pediatric (Infant) Vaccines Market

9.5 Pneumococcal – Total Vaccines Market

9.5.1 Pneumococcal – Adult Vaccines Market
9.5.2 Pneumococcal – Pediatric (Infant) Vaccines Market

9.6 Meningococcal – Total Vaccines Market

9.6.1 Meningococcal – Adult Vaccines Market
9.6.2 Meningococcal – Pediatric (Infant) Vaccines Market

9.7 Hepatitis – Total Vaccines Market

9.7.1 Hepatitis – Adult Vaccines Market
9.7.2 Hepatitis – Pediatric (Infant) Vaccines Market

9.8 TdaP and DTaP – Total Vaccines Market

9.8.1 TdaP – Adult Vaccines Market
9.8.2 DTaP – Pediatric (Infant) Vaccines Market

9.9 Travel and Miscellaneous – Vaccines Market

9.10 Haemophilus Influenzae Type B (HIB) – Vaccines Market

9.11 Combos (Combination) – Vaccines Market

9.12 Polio – Vaccines Market

9.13 Rotavirus – Vaccines Market

9.14 Varicella – Vaccines Market

9.14.1 Varicella – Adult Vaccines Market
9.14.2 Varicella – Pediatric (Infant) Vaccines Market


10. Disease wise – Numbers of Vaccinated People & Forecast

10.1 Influenza – Total Number of Vaccinated People

10.1.1 Influenza – Number of Vaccinated Adults
10.1.2 Influenza – Number of Vaccinated Infants

10.2 Cervical Cancer (HPV) – Number of Vaccinated People

10.3 Zoster (Shingles) – Number of Vaccinated People

10.4 MMR – Total Number of Vaccinated People

10.4.1 MMR – Number of Vaccinated Adults
10.4.2 MMR – Number of Vaccinated Infants (Pediatric)

10.5 Pneumococcal – Total Number of Vaccinated People

10.5.1 Pneumococcal – Number of Vaccinated Adults
10.5.2 Pneumococcal – Number of Vaccinated Infants

10.6 Meningococcal – Total Number of Vaccinated People

10.6.1 Meningococcal – Number of Vaccinated Adults
10.6.2 Meningococcal – Number of Vaccinated Infants

10.7 Hepatitis – Total Number of Vaccinated People

10.7.1 Hepatitis – Number of Vaccinated Adults
10.7.2 Hepatitis – Number of Vaccinated Infants

10.8 TdaP and DTaP – Total Number of Vaccinated People

10.8.1 TdaP – Number of Vaccinated Adults
10.8.2 DTaP – Number of Vaccinated Infants

10.9 Hib (Haemophilus Influenzae Type B) – Number of Vaaccinated Infants

10.10 Combos (Combination Vaccines) – Number of Vaccinated Infants

10.11 Polio – Number of Infants Immunized and Forecast

10.12 Rotavirus – Number of Vaccinated Infants

10.13 Varicella – Total Number of Vaccinated People

10.13.1 Varicella – Number of Vaccinated Adults
10.13.2 Varicella – Number of Vaccinated Infants


11. Vaccines – Products and Pipeline

11.1 GSK Vaccine Product Pipeline
11.2 Merck Vaccine Product Pipeline
11.3 Sanofi Vaccine Product Pipeline
11.4 Pfizer Vaccine Product Pipeline


12. Top Mergers and Acquisitions in the Vaccine Industry


13. Vaccines and Regulator’s Interventions

13.1 Making and Meeting Standards of Quality and Safety
13.2 Vaccine Funding


14. Vaccines Key Players Sales

14.1 GlaxoSmithKline, plc.

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Financial Insights

14.2 Merck & Co.

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Financial Insights

14.3 Sanofi Pasteur

14.3.1 Overview
14.3.2 Recent Development
14.3.3 Financial Insights

14.4 Pfizer, Inc.

14.4.1 Overview
14.4.2 Recent Development
14.4.3 Financial Insights

14.5 Thoracic Aortic Aneurysm (TAA)CSL Limited

14.5.1 Overview
14.5.2 Recent Development
14.5.3 Financial Insights



List of Figures

Figure-01: Global – Vaccines Market (Million US$), 2017 – 2021
Figure-02: Global – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-03: Global – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-04: Global – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-05: Global – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-06: Global – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-07: Global – Vaccinated People Volume (Million), 2017 – 2021
Figure-08: Global – Forecast for Vaccinated People Volume (Million), 2022 – 2027
Figure-09: Global – Adult Vaccinated People Volume (Million), 2017 – 2021
Figure-10: Global – Forecast for Adult Vaccinated People Volume (Million), 2022 – 2027
Figure-11: Global – Pediatric (Infant) Vaccinated People Volume (Million), 2017 – 2021
Figure-12: Global – Forecast for Pediatric (Infant) Vaccinated People Volume (Million), 2022 – 2027
Figure-13: Influenza – Total Vaccines Market (Million US$), 2017 – 2021
Figure-14: Influenza – Forecast for Total Vaccines Market (Million US$), 2022 – 2027
Figure-15: Influenza – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-16: Influenza – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-17: Influenza – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-18: Influenza – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-19: Cervical Cancer (HPV) – Vaccines Market (Million US$), 2017 – 2021
Figure-20: Cervical Cancer (HPV) – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-21: Zoster (Shingles) – Vaccines Market (Million US$), 2017 – 2021
Figure-22: Zoster (Shingles) – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-23: MMR – Total Vaccines Market (Million US$), 2017 – 2021
Figure-24: MMR – Forecast for Total Vaccines Market (Million US$), 2022 – 2027
Figure-25: MMR – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-26: MMR – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-27: MMR – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-28: MMR – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-29: Pneumococcal – Total Vaccines Market (Million US$), 2017 – 2021
Figure-30: Pneumococcal – Forecast for Total Vaccines Market (Million US$), 2022 – 2027
Figure-31: Pneumococcal – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-32: Pneumococcal – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-33: Pneumococcal – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-34: Pneumococcal – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-35: Meningococcal – Total Vaccines Market (Million US$), 2017 – 2021
Figure-36: Meningococcal – Forecast for Total Vaccines Market (Million US$), 2022 – 2027
Figure-37: Meningococcal – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-38: Meningococcal – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-39: Meningococcal – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-40: Meningococcal – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-41: Hepatitis – Total Vaccines Market (Million US$), 2017 – 2021
Figure-42: Hepatitis – Forecast for Total Vaccines Market (Million US$), 2022 – 2027
Figure-43: Hepatitis – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-44: Hepatitis – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-45: Hepatitis – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-46: Hepatitis – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-47: TdaP and DTaP – Total Vaccines Market (Million US$), 2017 – 2021
Figure-48: TdaP and DTaP – Forecast for Total Vaccines Market (Million US$), 2022 – 2027
Figure-49: TdaP – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-50: TdaP – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-51: DTaP – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-52: DTaP – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-53: Travel and Miscellaneous – Vaccines Market (Million US$), 2017 – 2021
Figure-54: Travel and Miscellaneous – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-55: Haemophilus Influenzae Type B (HIB) – Vaccines Market (Million US$), 2017 – 2021
Figure-57: Haemophilus Influenzae Type B (HIB) – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-56: Combos (Combination) – Vaccines Market (Million US$), 2017 – 2021
Figure-58: Combos (Combination) – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-59: Polio – Vaccines Market (Million US$), 2017 – 2021
Figure-60: Polio – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-61: Rotavirus – Vaccines Market (Million US$), 2017 – 2021
Figure-62: Rotavirus – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-63: Varicella – Vaccines Market (Million US$), 2017 – 2021
Figure-64: Varicella – Forecast for Vaccines Market (Million US$), 2022 – 2027
Figure-65: Varicella – Adult Vaccines Market (Million US$), 2017 – 2021
Figure-66: Varicella – Forecast for Adult Vaccines Market (Million US$), 2022 – 2027
Figure-67: Varicella – Pediatric (Infant) Vaccines Market (Million US$), 2017 – 2021
Figure-68: Varicella – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-69: Influenza – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-70: Influenza – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-71: Influenza – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-72: Influenza – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-73: Influenza – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-74: Influenza – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-75: Cervical Cancer (HPV) – Number of Vaccinated People (Million), 2017 – 2021
Figure-76: Cervical Cancer (HPV) – Forecast for Number of Vaccinated People (Million), 2022 – 2027
Figure-77: Zoster (Shingles) – Number of Vaccinated People (Million), 2017 – 2021
Figure-78: Zoster (Shingles) – Forecast for Number of Vaccinated People (Million), 2022 – 2027
Figure-79: MMR – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-80: MMR – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-81: MMR – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-82: MMR – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-83: MMR – Number of Vaccinated Infants (Pediatric) (Million), 2017 – 2021
Figure-84: MMR – Forecast for Number of Vaccinated Infants (Pediatric) (Million), 2022 – 2027
Figure-85: Pneumococcal – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-86: Pneumococcal – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-87: Pneumococcal – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-88: Pneumococcal – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-89: Pneumococcal – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-90: Pneumococcal – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-91: Meningococcal – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-92: Meningococcal – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-93: Meningococcal – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-94: Meningococcal – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-95: Meningococcal – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-96: Meningococcal – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-97: Hepatitis – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-98: Hepatitis – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-99: Hepatitis – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-100: Hepatitis – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-101: Hepatitis – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-102: Hepatitis – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-103: TdaP and DTaP – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-104: TdaP and DTaP – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-105: TdaP – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-106: TdaP – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-107: DTaP – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-108: DTaP – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-109: Hib (Haemophilus Influenzae Type B) – Number of Vaaccinated Infants (Million), 2017 – 2021
Figure-110: Hib (Haemophilus Influenzae Type B) – Forecast for Number of Vaaccinated Infants (Million), 2022 – 2027
Figure-111: Combos (Combination Vaccines) – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-112: Combos (Combination Vaccines) – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-113: Polio – Number of Infants Immunized and Forecast (Million), 2017 – 2021
Figure-114: Polio – Forecast for Number of Infants Immunized and Forecast (Million), 2022 – 2027
Figure-115: Rotavirus – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-116: Rotavirus – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-117: Varicella – Total Number of Vaccinated People (Million), 2017 – 2021
Figure-118: Varicella – Forecast for Total Number of Vaccinated People (Million), 2022 – 2027
Figure-119: Varicella – Number of Vaccinated Adults (Million), 2017 – 2021
Figure-120: Varicella – Forecast for Number of Vaccinated Adults (Million), 2022 – 2027
Figure-121: Varicella – Number of Vaccinated Infants (Million), 2017 – 2021
Figure-122: Varicella – Forecast for Number of Vaccinated Infants (Million), 2022 – 2027
Figure-123: GlaxoSmithKline, plc. – Global Revenue (Million US$), 2016 – 2021
Figure-124: GlaxoSmithKline, plc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-125: Merck & Co. – Global Revenue (Million US$), 2016 – 2021
Figure-126: Merck & Co. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-127: Sanofi Pasteur – Global Revenue (Million US$), 2016 – 2021
Figure-128: Sanofi Pasteur – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-129: Pfizer, Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-130: Pfizer, Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-131: Thoracic Aortic Aneurysm (TAA) CSL Limited – Global Revenue (Million US$), 2016 – 2021
Figure-132: Thoracic Aortic Aneurysm (TAA) CSL Limited – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Vaccine Market Share (Percent), 2017 – 2021
Table-02: Global – Forecast for Vaccine Market Share (Percent), 2022 – 2027
Table-03: Global – Vaccinated People Share (Percent), 2017 – 2021
Table-04: Global – Forecast for Vaccinated People Share (Percent), 2022 – 2027
Table-05: Global – Adult Vs Pediatric (Infant) Vaccines Market Share (Percent), 2017 – 2021
Table-06: Global – Forecast for Adult Vs Pediatric (Infant) Vaccines Market Share (Percent), 2022 – 2027
Table-07: Global – Adult Vs Pediatric (Infant) Vaccines Number Share (Percent), 2017 – 2021
Table-08: Global – Forecast for Adult Vs Pediatric (Infant) Vaccines Number Share (Percent), 2022 – 2027